Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]

DRUG4 trials

Sponsors

Hitendra Patel, University Hospital, Strasbourg, France, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Augusta University

Conditions

Melanoma (Skin)Metastatic MelanomaPancreatic Cancer Stage IVSmall Cell Lung CarcinomaSmall-cell Lung Cancer

Phase 1

Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis

CompletedNCT03949153

University Hospital, Strasbourg, FranceMelanoma (Skin)

Start: 2019-08-16End: 2022-03-18Updated: 2025-10-01

Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer

TerminatedNCT04173325

Augusta UniversitySmall-cell Lung Cancer, Small Cell Lung Carcinoma

Start: 2020-01-06End: 2022-05-26Updated: 2022-06-14

Phase 2

Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

CompletedNCT03697564

Hitendra PatelPancreatic Cancer Stage IV

Start: 2019-10-31End: 2023-07-13Updated: 2025-08-06

SBRT as a Vaccination for Metastatic Melanoma

WithdrawnNCT04042506

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMetastatic Melanoma

Start: 2019-11-26End: 2021-01-26Updated: 2021-04-12